BioSpace News Archive

Allergy Diagnostics Market to Reach a Value of US$3.8 Bn by 2024, Increasing Cases of Allergy Worldwide to Drive the Market

Albany NY, United States: The demand within the global market for allergy diagnostics has been rising on account of the growing culture of dust mites, bacterial agents, and other allergens, finds Transparency Market Research.

March 8, 2022
·
4 min read
X-ray Inspection Systems Technology Market New Development Opportunity and Upcoming Key Trends

The X-ray inspection systems technology market has been projected to grow at a noticeable speed in the forthcoming years.

March 8, 2022
·
5 min read
Biotech Bay

Calithera to Present Data Highlighting Newly Discovered Synthetic Lethal Target VPS4 at AACR 2022 Annual Meeting

Calithera Biosciences, Inc., a clinical-stage, precision oncology biopharmaceutical company, announced that it will present the first data from its preclinical synthetic lethality pipeline at the American Association for Cancer Research 2022 Annual Meeting, being held April 8-13, 2022, in New Orleans, LA.

March 8, 2022
·
5 min read
Biotech Bay

DNA Script Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022

DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) and DNA on demand, has been named to Fast Company ’s prestigious annual list of the World’s Most Innovative Companies for 2022.

March 8, 2022
·
5 min read
Lone Star Bio

Taysha Gene Therapies to Participate in the Oppenheimer 32nd Annual Virtual Healthcare Conference

Taysha Gene Therapies, Inc. announced its participation in two fireside chats at the Oppenheimer 32nd Annual Virtual Healthcare Conference on Monday, March 14, 2022, and Tuesday, March 15, 2022.

March 8, 2022
·
2 min read
Business

LumaCyte Fueled for Growth, Names Top Life Sciences Industry Executives to Board

LumaCyte Corporation announced the successful completion of an A round financing that will allow the company to accelerate its global expansion efforts and service the increasing global demand of its flagship product, Radiance ®.

March 8, 2022
·
3 min read
BioMidwest

Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, has been recognized on Fast Company’s annual list of the World’s Most Innovative Companies for 2022.

March 8, 2022
·
7 min read
Business

XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events

XOMA Corporation, a biotech royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, reported its 2021 financial results and provided a recent operations update.

March 8, 2022
·
13 min read
Business

Neuronetics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

Neuronetics, Inc. announced its financial and operating results for the fourth quarter and full year of 2021.

March 8, 2022
·
20 min read
InMed to Present at the 34th Annual Roth Conference

InMed Pharmaceuticals Inc. announces that Eric A. Adams, InMed’s President and Chief Executive Officer, will be presenting at the 34th Annual Roth Conference being held March 13-15, 2022.

March 8, 2022
·
4 min read